» Articles » PMID: 38509106

Autologous Cell Transplantation for Treatment of Colorectal Aganglionosis in Mice

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Mar 21
PMID 38509106
Authors
Affiliations
Soon will be listed here.
Abstract

Neurointestinal diseases cause significant morbidity and effective treatments are lacking. This study aimes to test the feasibility of transplanting autologous enteric neural stem cells (ENSCs) to rescue the enteric nervous system (ENS) in a model of colonic aganglionosis. ENSCs are isolated from a segment of small intestine from Wnt1::Cre;R26iDTR mice in which focal colonic aganglionosis is simultaneously created by diphtheria toxin injection. Autologous ENSCs are isolated, expanded, labeled with lentiviral-GFP, and transplanted into the aganglionic segment in vivo. ENSCs differentiate into neurons and glia, cluster to form neo-ganglia, and restore colonic contractile activity as shown by electrical field stimulation and optogenetics. Using a non-lethal model of colonic aganglionosis, our results demonstrate the potential of autologous ENSC therapy to improve functional outcomes in neurointestinal disease, laying the groundwork for clinical application of this regenerative cell-based approach.

Citing Articles

Recent advances in innovative biomaterials for promoting bladder regeneration: processing and functionalization.

Zhang Y, Ding F, Han J, Wang Z, Tian W Front Bioeng Biotechnol. 2025; 12():1528658.

PMID: 39834643 PMC: 11743525. DOI: 10.3389/fbioe.2024.1528658.


Mature enteric neurons have the capacity to reinnervate the intestine with glial cells as their guide.

Stavely R, Rahman A, Mueller J, Leavitt A, Han C, Pan W Neuron. 2024; 112(18):3143-3160.e6.

PMID: 39019043 PMC: 11427168. DOI: 10.1016/j.neuron.2024.06.018.

References
1.
Burns A, Goldstein A, Newgreen D, Stamp L, Schafer K, Metzger M . White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies. Dev Biol. 2016; 417(2):229-51. PMC: 5026875. DOI: 10.1016/j.ydbio.2016.04.001. View

2.
Stamp L . Cell therapy for GI motility disorders: comparison of cell sources and proposed steps for treating Hirschsprung disease. Am J Physiol Gastrointest Liver Physiol. 2017; 312(4):G348-G354. DOI: 10.1152/ajpgi.00018.2017. View

3.
Onufer E, Czepielewski R, Han Y, Courtney C, Sutton S, Sescleifer A . Lipid absorption and overall intestinal lymphatic transport are impaired following partial small bowel resection in mice. Sci Rep. 2022; 12(1):11527. PMC: 9262882. DOI: 10.1038/s41598-022-15848-6. View

4.
Boeckxstaens G, Pelckmans P, Herman A, Van Maercke Y . Involvement of nitric oxide in the inhibitory innervation of the human isolated colon. Gastroenterology. 1993; 104(3):690-7. DOI: 10.1016/0016-5085(93)91003-z. View

5.
Zhang S, Chen F, Jiang K, Yuan Z, Wang W . Comparative proteomic profiles of the normal and aganglionic hindgut in human Hirschsprung disease. Pediatr Res. 2014; 75(6):754-61. DOI: 10.1038/pr.2014.33. View